⌘K
t
GSK plc notified the market on 1 April 2026 of its total voting rights. As at 31 March 2026, the Company's issued share capital comprised 4,316,179,781 ordinary shares, of which 256,112,615 ordinary shares were held in Treasury. This resulted in a total of 4,060,067,166 voting rights in the Company.
| Date | 1 Apr 2026 |
| Time | 15:00:00 |
| Category | Capital structure |
| ID | 1145Z |
Issued: 1 April 2026, London UK
Total Voting Rights
 |
In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GSK plc (the 'Company') hereby notifies the market of the following:
The Company's issued share capital as at 31 March 2026 consisted of 4,316,179,781 shares of 31 ¼ pence each ('Ordinary Shares'), of which 256,112,615 Ordinary Shares were held in Treasury.
Therefore, the total number of voting rights in the Company is 4,060,067,166. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Notifications may be sent to company.secretary@gsk.com.
V A Whyte
Company Secretary
1 April 2026
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
Registered in England & Wales:
No. 3888792
Registered Office:
79 New Oxford Street
London
WC1A 1DG